Boston Scientific (BSX) financials · Finance & Quant Society

Income statement (USD)	Q2 2026 ended Jun 30, 2026	Q1 2026 ended Mar 31, 2026	Q4 2025 ended Dec 31, 2025	Q3 2025 ended Sep 30, 2025	Q2 2025 ended Jun 30, 2025	Q1 2025 ended Mar 31, 2025	Q4 2024 ended Dec 31, 2024	Q3 2024 ended Sep 30, 2024
Revenue	5.44B	5.20B	5.29B	5.07B	5.06B	4.66B	4.56B	4.21B
Cost of revenue	1.59B	1.59B	1.61B	1.52B	1.64B	1.45B	1.47B	1.31B
Gross profit	3.85B	3.61B	3.68B	3.54B	3.42B	3.21B	3.10B	2.90B
Research and development	554.00M	516.00M	569.00M	514.00M	526.00M	443.00M	459.00M	407.00M
Selling, general and admin	1.80B	1.78B	1.83B	1.74B	1.72B	1.60B	1.61B	1.56B
Operating expenses	2.67B	2.51B	2.85B	2.49B	2.60B	2.29B	2.42B	2.16B
Operating income	1.18B	1.10B	825.00M	1.05B	819.00M	921.00M	675.00M	733.00M
EBITDA	1.53B	1.45B	1.19B	1.17B	930.00M	1.25B	1.02B	835.00M
Interest expense	96.00M	90.00M	90.00M	87.00M	90.00M	82.00M	80.00M	79.00M
Income before tax	1.06B	1.16B	700.00M	939.00M	941.00M	805.00M	585.00M	669.00M
Income tax	155.00M	-176.00M	30.00M	183.00M	146.00M	133.00M	23.00M	200.00M
Net income	907.00M	1.34B	672.00M	755.00M	797.00M	674.00M	565.00M	469.00M
EPS	0.62	0.90	0.46	0.51	0.54	0.46	0.38	0.32
EPS (diluted)	0.61	0.90	0.45	0.51	0.53	0.45	0.38	0.32
Diluted shares	1.47B	1.50B	500.0K	1.50B	1.49B	1.49B	1.40M	1.49B

From Boston Scientific's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.

Boston Scientific

Charts

Report a problem